drugset
drugset / Trial / NCT01589822

The EVICEL® Gastrointestinal Study

NCT01589822 ↗

Phase 2 Completed 214 enrolled Ethicon, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) for use as an adjunct to gastrointestinal (GI) surgery.

Timeline

Start
2012-06
Primary completion
2014-01
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic — —

Indications

digestive system disorder